A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Conditions: Neuroblastoma; High-risk Neuroblastoma; Metastatic Neuroblastoma Interventions: Biological: OPT-821 (QS-21); Dietary Supplement: oral β-glucan Sponsors: Memorial Sloan Kettering Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Cancer | Cancer & Oncology | Cancer Vaccines | Diets | Neuroblastoma | Neurology | Nutrition | Oral Cancer | Research | Study | Vaccines